N
RMTI icon

Natixis’s Rockwell Medical RMTI Stock Holding History

Natixis’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-273
Closed -$201K – 905
2016
Q3 		$201K Hold
273
– – ﹤0.01% 500
2016
Q2 		$227K Buy
+273
New +$254K ﹤0.01% 374
2015
Q3 		– Sell
-255
Closed -$455K – 374
2015
Q2 		$455K Buy
+255
New +$324K 0.01% 265

Other funds holding RMTI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Natixis's RMTI Position: Q4 2016 in Review

Natixis sold out of Rockwell Medical (RMTI) in Q4 2016, closing a stake of 273 shares — an estimated $201K sold.

Natixis first reported a position in RMTI in Q2 2015 and held it in 3 quarters. The position peaked at $455K in Q2 2015. 85 funds tracked by Wall St. Rank hold RMTI as of Q4 2016.

  • Natixis reported no remaining Rockwell Medical position as of Q4 2016 after selling out during the quarter.
  • Natixis sold 273 Rockwell Medical shares in Q4 2016, an estimated $201K.
  • Natixis first reported a position in Rockwell Medical in Q2 2015 and held it in 3 quarters.
  • Natixis's Rockwell Medical position peaked at $455K in Q2 2015.
  • 85 funds tracked by Wall St. Rank held Rockwell Medical as of Q4 2016.

Based on Natixis's 13F filing for Q4 2016, filed 14 Feb 2017.